Horizons Ventures focuses on investing in disruptive and technology-focused start-ups. The firm was founded in 1999 and is based in Hong Kong. Some of the latest exits are Skype, Siri, Facebook, Summly, and Waze.

Horizons Ventures

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science to accelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

aMoon Fund

Horizon Venture is a Real estate company located in 2573 Clay Bank Rd, Fairfield, California, United States.

Horizon Ventures

Medial EarlySign

Medial EarlySign develops an AI algorithmic platform for the discovery of clinical insights that indicate the likelihood of disease from basic medical information, such as blood test results, and other EMR data.  Called AlgoMarkers, its predictive engines are built in collaboration with healthcare organizations, through the combination of 10s of millions of patient years-worth of data, clinical rigor and some of the most brilliant algorithmic minds.  The company develops clinical decision support and population health solutions that can assist in the early prediction of clinical outcomes related to cancers, metabolic, immune and infectious diseases. These tools are designed to place at the fingertips of healthcare organizations only those insights that could prove critical in disease management and prevention empowering them with proactive, predictive and personalized care management capabilities

<div><p>Medial Early Sign develops CDSS and population health management solutions to facilitate early detection and prevention of diseases such as cancers, metabolic conditions, autoimmune disorders, and infectious diseases</p></div>

Automation in clinical diagnostics to improve speed and accuracy in patient diagnosis and treatment.

Clinical Decision Support Systems

<div>
  <p>
    Medial Early Sign develops CDSS and population health management solutions to facilitate early detection and prevention of diseases such as cancers, metabolic conditions, autoimmune disorders, and infectious diseases 
  </p>
</div>


<div>
  <p>
    Clover Health is a health maintenance organization with Medicare. It is publicly held. The company operates two lines of business&mdash;insurance and non-insurance&mdash;and provides preferred provider organization (PPO) and health maintenance organization (HMO) plans to Medicare Advantage members. Clover Health also provides supplementary benefits and services like OTC/grocery allowances, hearing, fitness, dental, insulin savings, and other benefits. Its plans are said to include dental, vision and hearing, easy access to doctors, over-the-counter allowances, broad and open networks, prescription drug coverage, and The Clover Assistant.
  </p>
  <p>
  </p>
</div>


Clover Health

<div>
  <p>
    Digital Diagnostics, formerly IDx, is a pioneering AI diagnostics company founded with a mission to transform the quality, accessibility, equity, and affordability of healthcare worldwide through the application of technology in the medical diagnosis and treatment process. Founded by Michael Abramoff, MD, PhD, a fellowship-trained retina specialist, neuroscientist, and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build an autonomous AI platform that makes clinical decisions without human intervention, removing the diagnostic burden of common diseases from specialists. Digital Diagnostics is paving the way for autonomous AI diagnosis to become the new standard of care, helping to democratize healthcare and close care gaps to improve patient outcomes. By working closely with patient advocacy groups, federal regulators, and other quality of care and ethics-focused stakeholders, Digital Diagnostics is working with the healthcare system to enable the continued adoption of autonomous AI.
  </p>
</div>


Digital Diagnostics

<div>
  <p>
    Lunit is headquartered in Seoul, South Korea, and provides data-driven healthcare for cancer patients with the help of artificial intelligence. The company assists with the development of novel AI biomarkers that can be used in cancer detection and treatment. Lunit&rsquo;s product list includes Lunit INSIGHT CXR, Lunit INSIGHT MMG, Lunit SCOPE IO and Lunit SCOPE PD-L1. The company recently obtained FDA approval for chest X-ray AI solutions with the help of its Lunit INSIGHT CXR Triage&nbsp; providing chest radiographs and CT images. It has offices located in China, the Netherlands, and the USA.
  </p>
  <p>
  </p>
</div>


Lunit

<div>
  <p>
    Lumeon offers a range of workflow management solutions that support the creation of personalized care plans, test recommendations, and suggest interventions based on a patient’s progress
  </p>
</div>


Lumeon

<div>
  <p>
    Proscia offers digital and computational pathology solutions. Its AI-powered digital pathology platform Concentriq connects the entire pathology ecosystem, enabling reporting and analytics, workflow management, remote access, sharing, collaborations and consults, and image viewing and analysis. Users can view whole slide images, integrate LIS data, and launch Prosica AI and other AI. The software features flexible deployment, is infinitely scalable, leads in interoperability, and is AI-ready. The platform also includes Concentriq Dx, for diagnostic laboratories to accelerate their clinical practices, and Concentriq, for Research for life science research teams looking to put their pathology data to work.
  </p>
</div>


Proscia

In most cases, CDSSs are provided to healthcare providers

Uses digital mediums to generate actionable insights from health data

Uses AI/ML to output decisions/recommended actions based on databases of medical records

Uses IoT to connect databases with medical devices for decision support

Software that provides a list of possible diseases based on data collected from patients. Platforms are only used for initial assessments.

Medial EarlySign

Clinical Decision Support Systems

Key stats

EDGE Insights

Clinical Decision Support Systems: Upgrading the clinician’s toolbox

Company Brief

Funding

Investors

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless